Motion Sickness Clinical Trials 2023

What are the top hospitals conducting motion sickness research?

While motion sickness might seem like a minor inconvenience for some, it can significantly impact the lives of many individuals. Fortunately, several hospitals are leading the charge in conducting clinical trials to better understand and address this condition. In sunny Santa Monica, Santa Monica Clinical Trials is actively engaged in two ongoing studies on motion sickness. With a total of four trials to their name since recording their first trial in 2020, they are dedicated to finding effective solutions for those who suffer from this discomforting ailment.

On the other side of the country, NASA Johnson Space Center Neuroscience Laboratory in Houston joins the effort with two active motion sickness trials. As pioneers in space exploration and human physiology research, they embarked on their first recorded motion sickness trial only last year in 2021. Their unique perspective and expertise make them invaluable contributors to unraveling the mysteries behind this complex phenomenon.

In Baltimore, Johns Hopkins University delves into understanding motion sickness through its single active clinical trial on the subject. While their journey began just recently with their first recorded trial taking place in 2022, they bring a wealth of scientific knowledge and resources that promise significant contributions towards overcoming this challenge.

Meanwhile, at Naval Medical Research Unit located Dayton also explores options concerning one ongoing clinical investigation involving motion sickness while having conducted two experiments earlier which started back as early as2014.Their efforts align with military applications where preventing or mitigating symptoms of motion-induced nausea is crucial for naval personnel deployed aboard ships or submarines.

Lastly,Dartmouth-Hitchcock Medical Center contributes its part by currently undertaking an active study focusing solely on addressing problems associated with motionsickness.They have joined forces fairly recently alongside John Hopkins University since both projects initiated duringthe same period- 2022.Despite being relatively new entrants comparedto others mentioned above,yet Dartmouth-Hitchcock brings forth tremendous potential due toits strong reputation within healthcare sector.

Together these hospitals represent beacons of hope for people struggling with motion sickness, and their collective efforts promise to revolutionize the understanding and treatment of this condition. By conducting clinical trials in diverse locations across the United States, they ensure that individuals from all walks of life have access to potential breakthroughs. Through their dedication, we inch closer towards a future where travel-induced discomfort becomes a thing of the past.

Which are the best cities for motion sickness clinical trials?

When it comes to motion sickness clinical trials, several cities have emerged as leaders in research and development. Santa Monica, California, offers two active trials focusing on treatments like Tradipitant and Tradipitant High Dose. Houston, Texas, also hosts two ongoing studies investigating DPI-386 Nasal Gel and other potential solutions. Dayton, Ohio, is another city with two active trials exploring treatments like SWAN VPT JHU and Transderm Scop®. Lastly, Baltimore, Maryland has one active trial examining SWAN VPT JHU among others. Additionally, Lebanon, New hampshire conducts a single trial evaluating the effectiveness of Scopolamine for motion sickness treatment. These cities provide individuals dealing with motion sickness access to cutting-edge clinical trials that pave the way for advancements in care and improved quality of life.

Which are the top treatments for motion sickness being explored in clinical trials?

Clinical trials are paving the way for new treatments in combating motion sickness. Among the frontrunners is DPI-386 Nasal Gel, which has shown promise in two active trials and a total of six motion sickness trials since its introduction in 2018. Tradipitant, another contender, is being explored through one ongoing trial and has been featured in two all-time motion sickness studies since 2018. Additionally, scopolamine stands out with one active trial and four all-time motion sickness trials dating back to 2014. Finally, tradipitant high dose shows potential as well with one ongoing trial and a single all-time motion sickness study initiated in 2020. Through these innovative clinical investigations, researchers aim to alleviate the discomfort of individuals experiencing motion-induced nausea and dizziness.

What are the most recent clinical trials for motion sickness?

Exciting advancements are being made in the field of motion sickness treatment, with recent clinical trials offering promising options for those affected. One notable trial focuses on tradipitant, a potential breakthrough medication currently in Phase 3 testing for motion sickness relief. Another study explores the efficacy of scopolamine, which has entered Phase 1 trials as a possible treatment option. Additionally, DPI-386 Nasal Gel is being investigated through Phase 2 studies to assess its effectiveness in combating motion sickness symptoms. With these ongoing trials showcasing innovative approaches and potential solutions, individuals suffering from motion sickness can look forward to improved management strategies in the near future.

What motion sickness clinical trials were recently completed?

In the realm of motion sickness research, a notable clinical trial has recently concluded. The study focused on evaluating the effectiveness of DPI-386 Nasal Gel as a potential treatment for this common ailment. Sponsored by Repurposed Therapeutics, Inc., the trial reached its completion in August 2022. This milestone brings us one step closer to discovering more effective interventions for individuals susceptible to motion sickness, offering hope and relief for those affected by this disruptive condition.